VIDEO: Orasis closes $78 million in financing

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.

In addition, Smith discussed a partnership with Optus Pharmaceutical, a pharmaceutical company based in South Korea.

“The aspiration is to continue expanding into other key jurisdictions around the world, and we will be reporting on those as they develop in the coming months,” he said.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures:
Smith reports being president and chief operating officer of Orasis Pharmaceuticals.

Read more about

This post was originally published on this site